Exagen Inc. Announces Select Preliminary 2025 Financial Results
Exagen Inc. (XGN)
Last exagen inc. earnings: 3/25 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth quarter and year ended December 31, 2025, in line with prior financial guidance. Select Preliminary Unaudited 2025 Results Revenue Three Months EndedDecember 31, 2025 Twelve Months EndedDecember 31, 2025Total Revenue$16M to $17M $66M to $67MYear-Over-Year Growth17% to 24% 19% to 20% Other Twelve Months EndedDecember 31, 2025AVISE CTD Volume136,000 to 137,000AVISE CTD Trailing 12-month (TTM) average selling price$441 to $445Year-end cash and cash equivalents$32M The select preliminary unaudited financial results reported today represent: Record full year 2025 revenue, an increase of at least 19% over 2024AVISE CTD trailing 12-month (TTM) ASP expansion by at least $30 compared to 2024AVISE CTD test volume growth of at least 13,000, an 11% increase over 2024Year-end cash and cash e
Show less
Read more
Impact Snapshot
Event Time:
XGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XGN alerts
High impacting Exagen Inc. news events
Weekly update
A roundup of the hottest topics
XGN
News
- How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story [Yahoo! Finance]Yahoo! Finance
- Exagen Inc. Announces Select Preliminary 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- How the Narrative Surrounding Exagen Is Evolving After New Guidance and Price Target Upgrades [Yahoo! Finance]Yahoo! Finance
- Exagen Inc. to Participate in Fourth Quarter Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Exagen Inc. to Participate in Fourth Quarter Investor ConferencesGlobeNewswire
XGN
Earnings
- 11/4/25 - Miss
XGN
Sec Filings
- 1/12/26 - Form 8-K
- 11/4/25 - Form 10-Q
- 11/4/25 - Form 8-K
- XGN's page on the SEC website